Public Sector Pension Investment Board (PSP Investments)’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-228,308
Closed -$2.21M 1504
2021
Q2
$2.21M Sell
228,308
-8,400
-4% -$79.1K 0.01% 1055
2021
Q1
$2.54M Buy
236,708
+2,397
+1% +$29.6K 0.02% 853
2020
Q4
$3.44M Buy
234,311
+29,581
+14% +$427K 0.03% 622
2020
Q3
$2.9M Buy
+204,730
New +$2.04M 0.02% 679

Other funds holding TRIL

Public Sector Pension Investment Board (PSP Investments)'s TRIL Position: Q3 2021 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Trillium Therapeutics Inc. (TRIL) in Q3 2021, closing a stake of 228,308 shares — an estimated $2.21M sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in TRIL in Q3 2020 and held it in 4 quarters. The position peaked at $3.44M in Q4 2020. 182 funds tracked by Wall St. Rank hold TRIL as of Q3 2021.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Trillium Therapeutics Inc. position as of Q3 2021 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 228,308 Trillium Therapeutics Inc. shares in Q3 2021, an estimated $2.21M.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Trillium Therapeutics Inc. in Q3 2020 and held it in 4 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Trillium Therapeutics Inc. position peaked at $3.44M in Q4 2020.
  • 182 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q3 2021.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q3 2021, filed 12 Nov 2021.